Reset filter
Keywords
Urinprov ×
Mostra di più Keywords
Sommario
  1. 1. Test clinico
  2. 2. Documentazione di routine
  3. 3. Registro / studio di coorte
  4. 4. Garanzia di qualità
  5. 5. Dati Standard
  6. 6. Risultato segnalato dal paziente
  7. 7. Specialità mediche
Modelli di dati selezionati

Devi effettuare il log in per selezionare i modelli di dati da scaricare per successive analisi

142 Risultati di ricerca.
rilevanza Valutazione Più recente Meno recente

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V10) Blood/ Urinanalysis 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V10) Blood/ Urinanalysis 2009-011417-24

- 01/12/16 - 1 modulo, 2 itemgroups, 31 elementi, 1 linguaggio
Itemgroups: Laboratory results Blood chemistry, Urinanalysis
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V9) Blood/ Urinanalysis 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V9) Blood/ Urinanalysis 2009-011417-24

- 23/11/16 - 1 modulo, 2 itemgroups, 31 elementi, 1 linguaggio
Itemgroups: Laboratory results Blood chemistry, Urinanalysis
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V8) Blood/ Urinanalysis 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V8) Blood/ Urinanalysis 2009-011417-24WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V7) Blood/ Urinanalysis 2009-011417-24

- 23/11/16 - 1 modulo, 2 itemgroups, 31 elementi, 1 linguaggio
Itemgroups: Laboratory results Blood chemistry, Urinanalysis
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V7) Blood/ Urinanalysis 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V7) Blood/ Urinanalysis 2009-011417-24WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 2 laboratory results (V7) Blood/ Urinanalysis 2009-011417-24

- 23/11/16 - 1 modulo, 2 itemgroups, 31 elementi, 1 linguaggio
Itemgroups: Laboratory results Blood chemistry, Urinanalysis
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 1 laboratory results (V6) Blood/ Urinanalysis 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 1 laboratory results (V6) Blood/ Urinanalysis 2009-011417-24

- 23/11/16 - 1 modulo, 2 itemgroups, 31 elementi, 1 linguaggio
Itemgroups: Laboratory results Blood chemistry, Urinanalysis
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 1 laboratory results (V4) Blood/ Urinanalysis 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 1 laboratory results (V4) Blood/ Urinanalysis 2009-011417-24

- 23/11/16 - 1 modulo, 2 itemgroups, 31 elementi, 1 linguaggio
Itemgroups: Laboratory results Blood chemistry, Urinanalysis
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 1 laboratory results (V5) Blood/ Urinanalysis 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 1 laboratory results (V5) Blood/ Urinanalysis 2009-011417-24

- 23/11/16 - 1 modulo, 2 itemgroups, 31 elementi, 1 linguaggio
Itemgroups: Laboratory results Blood chemistry, Urinanalysis
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 1 laboratory results (V2)Blood/ Urinanalysis 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 1 laboratory results (V2)Blood/ Urinanalysis 2009-011417-24

- 23/11/16 - 1 modulo, 2 itemgroups, 31 elementi, 1 linguaggio
Itemgroups: Laboratory results Blood chemistry, Urinanalysis
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Laboratory results Blood/ Urinanalysis 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Laboratory results Blood/ Urinanalysis 2009-011417-24

- 23/11/16 - 1 modulo, 2 itemgroups, 31 elementi, 1 linguaggio
Itemgroups: Laboratory results Blood chemistry, Urinanalysis
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 1 laboratory results (V3) Blood/ Urinanalysis 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 1 laboratory results (V3) Blood/ Urinanalysis 2009-011417-24

- 23/11/16 - 1 modulo, 2 itemgroups, 31 elementi, 1 linguaggio
Itemgroups: Laboratory results Blood chemistry, Urinanalysis
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial